جست‌وجوی استاد و پژوهشگر

• Proteomics
• Ubiquitin Signaling
• Transcription Regulation
• +۶ مورد دیگر

Karel Bezstarosti is an active Researcher in the Department of Biochemistry at Erasmus MC, Faculty of Medicine. His research spans multiple areas of molecular and cellular biochemistry with particular expertise in proteomics, ubiquitin signaling pathways, and DNA repair mechanisms. He maintains active collaborations within Erasmus MC and with international research teams. Bezstarosti's research interests focus on proteomics , ubiquitin signaling , transcription regulation , and mass spectrometry applications. His work particularly examines protein modification systems, DNA repair mechanisms including nucleotide excision repair and base excision repair, and the dynamics of molecular interactions in cellular processes. His fingerprint analysis shows strong concentrations in proteomics (100%), ubiquitin pathways (70%), transcription regulation (66%), and mass spectrometry (63%). Recent publications demonstrate Bezstarosti's focus on deubiquitinating enzymes, neuronal differentiation mechanisms, immunopeptidome analysis for vaccine development, and transcription-coupled DNA repair. His work bridges basic biochemical mechanisms with potential clinical applications, particularly in neurodevelopmental disorders and cancer immunotherapy. The consistent publication record in high-impact journals like Nature Chemical Biology, Genes and Development, and Molecular Cell indicates sustained research productivity. Bezstarosti maintains active research collaborations across multiple institutions, with recent external collaborations spanning various countries as indicated by the network visualization in his profile. His work shows interdisciplinary connections between biochemistry, molecular biology, neuroscience, and immunology.

• T Cell Immunology
• Chromatin Structure and Epigenetics
• Transcriptional Regulation
• +۴ مورد دیگر

Matthew E. Pipkin is an Associate Professor in the Department of Immunology & Microbiology at the University of Florida, where he leads the Pipkin Lab at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology. His research focuses on chromatin structure and transcriptional regulation in T cell differentiation, with particular emphasis on cytotoxic T lymphocyte (CTL) development for viral immunity and cancer immunotherapy. Dr. Pipkin's research interests center on how chromatin organization and transcription factors establish and maintain T cell differentiation states. His lab pioneered novel approaches including high-resolution chromatin mapping, Prf1 reporter systems for tracking CTLs in vivo, and the first genome-scale RNAi screens in T cells during viral infections. Key research areas include: Transcriptional regulation of CD8+ T cell memory formation Epigenetic control of effector and memory T cell differentiation Chromatin regulatory factors in durable immunity Tumor microenvironment interactions with CTLs Novel screening platforms for immune cell function His publication record demonstrates significant contributions to understanding T cell differentiation mechanisms, with high-impact papers in Immunity, Nature, and Cell. Current research directions include elucidating multipotency in CD8 T cell memory and nuclear receptor networks in mucosal immunity. Dr. Pipkin serves as Principal Investigator on multiple active NIH-funded grants including: Nuclear Receptor Networks in Mucosal Immune Regulation (NIAID) Transcription factor regulation of CD4/CD8 T cell differentiation (NIAID) Elucidating the epigenetic landscape of neurofibromatosis (NINDS) His lab trains numerous graduate students and postdoctoral fellows, with alumni securing positions at leading institutions including UPenn, Dana-Farber Cancer Institute, and Binzhou Medical University. The Pipkin Lab maintains active collaborations with the Solt Lab (nuclear receptors), Sundrud Lab (mucosal immunity), Crotty Lab (Tfh cells), and Goldrath Lab (T cell memory).

Adam Averyمشاهده پروفایل

استادیار

• Biochemistry
• Cytoskeletal Proteins
• Molecular Biology
• +۴ مورد دیگر

Adam Avery, Ph.D., serves as Assistant Professor in the Department of Chemistry within Oakland University's College of Arts and Sciences. His research focuses on cytoskeletal proteins, particularly the spectrin superfamily, and their role in neurological and cardiac disorders through molecular, biochemical, and genetic approaches. Education: Postdoctoral Research Fellow, University of Minnesota (2012-2018) Research Scientist, Originus, Inc. (2006-2012) Ph.D. in Biological Chemistry, University of Michigan (2001-2006) B.S. in Biochemistry, Oakland University (1997-2001) Research Focus: Dr. Avery's laboratory investigates how mutations in β-spectrin and α-actinin cause brain and heart disorders at the molecular level. His team combines in vitro biochemical techniques—including quantitative time-resolved FRET assays—with Drosophila melanogaster genetics to study spectrin's role in dendritic arbor formation and neuronal function. A key translational effort involves high-throughput drug screening with University of Minnesota collaborators to identify small-molecule modulators of mutant spectrin proteins. Publication Trends: Recent work (2016-2017) centers on β-III-spectrin mutations in spinocerebellar ataxia, revealing structural mechanisms of actin binding dysfunction and cytoskeletal impacts on neuronal morphology. Publications span structural biology, neurobiology, and translational drug discovery, consistently leveraging Drosophila models to bridge molecular findings with organism-level phenotypes. Honors: Michael B. O'Connor Outstanding Postdoc Award (2018) Minnesota Muscle Training Program Fellowship (2016-2018) National Ataxia Foundation Post-doctoral Fellowship (2014) Cellular Biotechnology Training Program Pre-doctoral Fellowship (2002-2005) Training & Collaboration: Dr. Avery mentors undergraduate and graduate students in a multidisciplinary environment spanning single-molecule biophysics and whole-organism genetics. His drug-discovery pipeline involves active collaboration with University of Minnesota researchers, though specific grant mechanisms are not detailed in available materials. Laboratory Approach: The Avery Lab integrates quantitative biochemistry, live-cell imaging, and Drosophila genetics to dissect spectrin-family protein functions, emphasizing how disease mutations alter molecular interactions and neuronal architecture while pursuing therapeutic interventions.